Tumor necrosis factor α and endothelin-1 increase p-glycoprotein expression and transport activity at the blood-brain barrier

Molecular Pharmacology

Volumn 71, Issue 3, 2007, Pages 667-675

  Bauer, Björn ^a   Hartz, Anika M S ^a   Miller, David S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GLYCOPROTEIN P; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; ENDOTHELIN-1; MALE; NF-KAPPA B; P-GLYCOPROTEIN; PROTEIN KINASE C; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847094700     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029512     Document Type: Article

References (40)

1. Ali S and Mann DA (2004) Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 22:67-79.
2. Bauer B, Hartz AM, Fricker G, and Miller DS (2004) Pregnane X receptor upregulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66:413-419.
3. Begley DJ (2004a) ABC transporters and the blood-brain barrier. Curr Pharm Des 10:1295-1312.
4. Begley DJ (2004b) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 104:29-45.
5. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, and Bours V (2003) NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22:90-97.
6. Chakravarty S and Herkenham M (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25:1788-1796.
7. Chen F and Shi X (2002) Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species. Environ Health Perspect 110 Suppl 5:807-811.
8. Crack PJ and Taylor JM (2005) Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38:1433-1444.
9. Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T, Bernhardt G, Graeff C, Farber L, Gschaidmeier H, et al. (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Investig 110:1309-1318.
10. Goralski KB, Hartmann G, Piquette-Miller M, and Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35-48.
11. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, and Oksche A (2004) Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279:27679-27687.
12. Harada N, Himeno A, Shigematsu K, Sumikawa K, and Niwa M (2002) Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 22:207-226.
13. Hartz AM, Bauer B, Fricker G, and Miller DS (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol Pharmacol 66:387-394.
14. Hartz AM, Bauer B, Fricker G, and Miller DS (2006) Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol 69:462-470.
15. Hayashi K, Pu H, Tian J, Andras IE, Lee YW, Hennig B, and Toborek M (2005) HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. J Neurochem 93:1231-1241.
16. Huber JD, Egleton RD, and Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719-725.
17. Konsman JP, Vigues S, Mackerlova L, Bristow A, and Blomqvist A (2004) Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472:113-129.
18. Liu ZG (2005) Molecular mechanism of TNF signaling and beyond. Cell Res 15:24-27.
19. Loscher W and Potschka H (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6:591-602.
20. Mandi Y, Ocsovszki I, Szabo D, Nagy Z, Nelson J, and Molnar J (1998) Nitric oxide production and MDR expression by human brain endothelial cells. Anticancer Res 18:3049-3052.
21. Martindale JL and Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15.
22. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, and Fricker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58:1357-1367.
23. Nadeau S and Rivest S (1999) Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93:1449-1464.
24. Nguyen MD, Julien JP, and Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216-227.
25. Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, and Smith DH (1999) Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma 16:1023-1034.
26. Nwaozuzu OM, Sellers LA, and Barrand MA (2003) Signalling pathways influencing basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier. J Neurochem 87:1043-1051.
27. Rivest S (2003) Molecular insights on the cerebral innate immune system. Brain Behav Immun 17:13-19.
28. Schinkel AH, Wagenaar E, Mol CA, and van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Investig 97:2517-2524.
29. Schramm U, Fricker G, Wenger R, and Miller DS (1995) P-glycoprotein- mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol 268:F46-F52.
30. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, and Hermann DM (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9:487-488.
31. Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP, and Scheff SW (1999) Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 19:6248-6256.
32. Taylor JM and Crack PJ (2004) Impact of oxidative stress on neuronal survival. Clin Exp Pharmacol Physiol 31:397-406.
33. Terlouw SA, Graeff C, Smeets PH, Fricker G, Russel FG, Masereeuw R, and Miller DS (2002) Short- and long-term influences of heavy metals on anionic drug efflux from renal proximal tubule. J Pharmacol Exp Ther 301:578-585.
34. Theron D, Barraud de Lagerie S, Tardivel S, Pelerin H, Demeuse P, Mercier C, Mabondzo A, Farinotti R, Lacour B, Roux F, et al. (2003) Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol 66:579-587.
35. Thevenod F, Friedmann JM, Katsen AD, and Hauser IA (2000) Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-κB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 275:1887-1896.
36. Trickler WJ, Mayhan WG, and Miller DW (2005) Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res 1048:24-31.
37. Turner AJ and Murphy LJ (1996) Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51:91-102.
38. Yang K, Mu XS, and Hayes RL (1995) Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats. Neurosci Lett 197:101-104.
39. Zhao YL, Du J, Kanazawa H, Cen XB, Takagi K, Kitaichi K, Tatsumi Y, Takagi K, Ohta M, and Hasegawa T (2002) Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice. Brain Res 956:246-253.
40. Zhou G and Kuo MT (1997) NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. J Biol Chem 272:15174-15183.